| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anticoagulant treatment in COVID-19: a narrative review
|
Carfora, Vincenzo
|
|
|
51 |
3 |
p. 642-648
|
article
|
| 2 |
A pilot study of procoagulant platelet extracellular vesicles and P-selectin increase during induction treatment in acute lymphoblastic leukaemia paediatric patients: two new biomarkers of thrombogenic risk?
|
Pluchart, Claire
|
|
|
51 |
3 |
p. 711-719
|
article
|
| 3 |
Association of ABO blood group type with cardiovascular events in COVID-19
|
Nauffal, Victor
|
|
|
51 |
3 |
p. 584-586
|
article
|
| 4 |
Biomarkers of platelet activation and cardiovascular risk in the DAPT trial
|
Berg, David D.
|
|
|
51 |
3 |
p. 675-681
|
article
|
| 5 |
Can fibrinolytic therapy be clinically useful in severe pneumonia caused by COVID-19?
|
Bornstein, Rafael
|
|
|
51 |
3 |
p. 633-636
|
article
|
| 6 |
Characteristics and risk factors of deep vein thrombosis in hemiplegic, healthy and bilateral limbs of hemiplegic patients: a 10-year retrospective study
|
Liang, Feng
|
|
|
51 |
3 |
p. 798-804
|
article
|
| 7 |
Clinical characteristics and outcomes of patients with venous thromboembolism according to diagnosis on weekends versus on weekdays
|
Yamashita, Yugo
|
|
|
51 |
3 |
p. 779-788
|
article
|
| 8 |
Clinical outcomes after percutaneous coronary intervention for early versus late and very late stent thrombosis: a systematic review and meta-analysis
|
Yang, Yi-Xing
|
|
|
51 |
3 |
p. 682-692
|
article
|
| 9 |
Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19
|
Wang, Xin
|
|
|
51 |
3 |
p. 657-662
|
article
|
| 10 |
Correction to: The perplexity of catheter-directed thrombolysis for deep venous thrombosis: the approaches play an important role
|
Qian, Cheng
|
|
|
51 |
3 |
p. 833
|
article
|
| 11 |
COVID-19 and its sequelae: a platform for optimal patient care, discovery and training
|
Becker, Richard C.
|
|
|
51 |
3 |
p. 587-594
|
article
|
| 12 |
COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis
|
Fan, Bingwen Eugene
|
|
|
51 |
3 |
p. 663-674
|
article
|
| 13 |
Decreased pulmonary artery distensibility as a marker for severity in acute pulmonary embolism patients undergoing ECG-gated CTPA
|
Yang, Fei
|
|
|
51 |
3 |
p. 748-756
|
article
|
| 14 |
Direct oral anticoagulants are effective and safe in the treatment of venous thromboembolism and atrial fibrillation in morbidly obese patients
|
Mohamed, Mouhand F. H.
|
|
|
51 |
3 |
p. 701-702
|
article
|
| 15 |
Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate
|
Osawa, Itsuki
|
|
|
51 |
3 |
p. 649-656
|
article
|
| 16 |
Effects of clinical depression on left ventricular dysfunction in patients with acute coronary syndrome
|
Sama, Jacob
|
|
|
51 |
3 |
p. 693-700
|
article
|
| 17 |
Evaluation of relationship between KEAP1 gene and genetic susceptibility of deep vein thrombosis after orthopedic surgery in Han Chinese population
|
Huang, Wei
|
|
|
51 |
3 |
p. 617-624
|
article
|
| 18 |
Evidence of systemic endothelial injury and microthrombosis in hospitalized COVID-19 patients at different stages of the disease
|
Della Rocca, Domenico G.
|
|
|
51 |
3 |
p. 571-576
|
article
|
| 19 |
Excessive fibrinolysis detected with thromboelastography in a case of amniotic fluid embolism: fibrinolysis may precede coagulopathy
|
Fudaba, M.
|
|
|
51 |
3 |
p. 818-820
|
article
|
| 20 |
Factors influencing cognitive performance after 1-year treatment with direct oral anticoagulant in patients with atrial fibrillation and previous ischemic stroke: a pilot study
|
Cappellari, Manuel
|
|
|
51 |
3 |
p. 767-778
|
article
|
| 21 |
High prevalence of early asymptomatic venous thromboembolism in anticoagulated COVID-19 patients hospitalized in general wards
|
Le Jeune, Sylvain
|
|
|
51 |
3 |
p. 637-641
|
article
|
| 22 |
Immature platelets in patients hospitalized with Covid-19
|
Cohen, Amir
|
|
|
51 |
3 |
p. 608-616
|
article
|
| 23 |
Impact of COVID-19 on monitoring of therapeutic unfractionated heparin
|
Adie, Sarah K.
|
|
|
51 |
3 |
p. 827-829
|
article
|
| 24 |
MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation
|
Guarino, Maria Luisa
|
|
|
51 |
3 |
p. 625-632
|
article
|
| 25 |
Platelet count trends and response to fondaparinux in a cohort of heparin-induced thrombocytopenia suspected patients after pulmonary endarterectomy
|
Li, Ji-Feng
|
|
|
51 |
3 |
p. 703-710
|
article
|
| 26 |
Platinoid effects on human plasmatic coagulation kinetics: a viscoelastic analysis
|
Nielsen, Vance G.
|
|
|
51 |
3 |
p. 577-583
|
article
|
| 27 |
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study
|
Ageno, Walter
|
|
|
51 |
3 |
p. 561-570
|
article
|
| 28 |
Rescue catheter-based therapies for the treatment of acute massive pulmonary embolism after unsuccessful systemic thrombolysis
|
Gong, Maofeng
|
|
|
51 |
3 |
p. 805-813
|
article
|
| 29 |
Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis
|
Abdel-Maboud, Mohamed
|
|
|
51 |
3 |
p. 830-832
|
article
|
| 30 |
Stress hyperglycemia is predictive of worse outcome in patients with acute ischemic stroke undergoing intravenous thrombolysis
|
Merlino, Giovanni
|
|
|
51 |
3 |
p. 789-797
|
article
|
| 31 |
The clinical characteristic, diagnosis, treatment, and prognosis of cerebral cortical vein thrombosis: a systematic review of 325 cases
|
Song, Si-ying
|
|
|
51 |
3 |
p. 734-740
|
article
|
| 32 |
The perplexity of catheter-directed thrombolysis for deep venous thrombosis: the approaches play an important role
|
Qian, Chengheng
|
|
|
51 |
3 |
p. 757-766
|
article
|
| 33 |
Thromboprophylaxis for patients with newly diagnosed vs. recurrent cancers: a post-hoc analysis of the avert trial
|
Zhang, James
|
|
|
51 |
3 |
p. 720-724
|
article
|
| 34 |
Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review
|
Jenner, William J.
|
|
|
51 |
3 |
p. 595-607
|
article
|
| 35 |
Treatment and outcomes of heparin-induced thrombocytopenia (HIT) in patients with neoplasm, a case series
|
Lai, Chieh Min Benjamin
|
|
|
51 |
3 |
p. 725-733
|
article
|
| 36 |
Ultrastructure of a late-stage bacterial endocarditis valve vegetation
|
Baudoin, Jean-Pierre
|
|
|
51 |
3 |
p. 821-826
|
article
|
| 37 |
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
|
Angiolillo, Dominick J.
|
|
|
51 |
3 |
p. 741-747
|
article
|
| 38 |
Utility of the 4Ts score in excluding heparin-induced thrombocytopenia in lung transplant recipients
|
Wu, Sara
|
|
|
51 |
3 |
p. 814-817
|
article
|
Journal description